Patient Engagement Survey Regarding Future Double-Blinded, Randomized Controlled Trial of Tapering of Chronic Opioid Therapy

Autor: Terrence J. Witt, Jared James, Benjamin Lai
Rok vydání: 2019
Předmět:
medicine.medical_specialty
tapering
Patient engagement
lcsh:Computer applications to medicine. Medical informatics
01 natural sciences
law.invention
chronic opioid therapy (COT)
primary care
03 medical and health sciences
0302 clinical medicine
Double-Blind Method
deprescribing
Randomized controlled trial
law
Surveys and Questionnaires
medicine
Humans
030212 general & internal medicine
0101 mathematics
Original Research
Community and Home Care
chronic noncancer pain (CNCP)
business.industry
lcsh:Public aspects of medicine
010102 general mathematics
Public Health
Environmental and Occupational Health

Chronic pain
lcsh:RA1-1270
Opioid-Related Disorders
medicine.disease
Discontinuation
Analgesics
Opioid

Opioid
Family medicine
Respondent
lcsh:R858-859.7
opioid crisis
Chronic Pain
Patient Participation
Thematic analysis
Deprescribing
down titration
business
medicine.drug
Zdroj: Journal of Primary Care & Community Health
Journal of Primary Care & Community Health, Vol 10 (2019)
ISSN: 2150-1327
DOI: 10.1177/2150132719890231
Popis: Objective: There is a lack of evidence regarding tapering opioid medications in patients with chronic non-cancer pain. The purpose of this survey was to gather perspectives on future research into opioid tapering from utilizers of chronic opioid therapy (COT) or other people affected by chronic noncancer pain. Methods: The survey was distributed in paper form to patients on COT and via an online platform to patients self-enrolled in the chronic pain patient engagement group. The survey included a layman’s description of a possible tapering trial of opioid medications and elicited binary responses regarding willingness to participate and reasoning as well as qualitative freeform responses. Thematic analysis was performed to identify themes in narrative responses. Results: A total of 190 surveys were returned with 72.1% of all respondents answering positively regarding their willingness to participate in a proposed study. The most common reasons for participating in the study included concerns regarding opioid dependence, adding to society’s knowledge of opioid medications, and determining if the respondent would personally receive benefit from opioid medications. Patients recently on COT felt it was important to be able to withdraw from the study and return to usual care at any time (41.8% for recent COT and 15.5% for no recent COT, P < .05). The most common reason for unwillingness to participate was that respondents did not feel they had enough information to feel comfortable participating. The narrative responses showed a group of respondents felt COT was the only answer to their or their loved ones’ chronic pain and that a study would demonstrate the need to continue these medications long-term. There were also stories of side effects and dependence with decreasing effectiveness of opioids for pain control. When prompted to comment on study design, respondents indicated the study should include alternative pain management options. This was accompanied by responses with the assumption that pain will worsen as opioid medications are decreased. Conclusion: Patient concerns regarding opioid medications and discontinuation reflect the lack of evidence available to prescribers. There appears to be patient support for future research into the effects of tapering opioid medications.
Databáze: OpenAIRE